Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors - Concepedia

Concepedia

Publication | Open Access

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

DOI Full Paper Access

855

Citations

27

References

2016

Year

Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev, Mitesh J. Borad, Yoon‐Koo Kang, Jay Stoudemire, Andreas G. Bader, Sinil Kim, David S. Hong

Investigational New Drugs

Tumor BiologyMedicinePathologyAdvanced Solid TumorsExtracellular MicrovesiclesCancer BiologyMicrorna DetectionOncologyCell BiologyCancer ResearchLiposomal Mir-34a Mimic

References

	Year	Citations

Page 1

Page 1